X-Chem’s Noor Shaker Recognized for Achievements in AI for Drug Discovery
WALTHAM, Mass.–(BUSINESS WIRE)–X-Chemthe pioneer of DNA-encoded library (LED) and artificial intelligence (AI) technology for small molecule drug discovery, today announced that Senior Vice President and General Manager Nour Shaker was named winner of the Artificial Intelligence Excellence Awards Program of the business intelligence group. Shaker is one of six to receive an individual award, which recognizes people, organizations and products that bring AI to life and apply it to solve real problems.
“I’m very passionate about data and pushing the boundaries of what’s possible with AI,” Shaker said. “AI is poised to transform almost every aspect of our lives and culture, and its use to increase the efficiency of drug discovery has grown dramatically in recent years. Our team’s ultimate goal at X-Chem is to cure disease – and we believe that our AI technology, combined with our LED and medicinal chemistry expertise, will help enable this sea change in drug discovery.
Shaker has a track record of accomplishments in the field of AI, including numerous patents and published papers in the field and its application to drug discovery and AI. She also sits on advisory boards on AI and diversity for several prestigious organizations and universities.
“We are very proud to name Noor Shaker as the winner of our inaugural Artificial Intelligence Excellence Awards program,” said Maria Jimenez, Head of Nominations for Business Intelligence Group. “It was clear to our judges that Noor was using AI to improve the lives of its customers and employees. Congratulations to the entire team!”
X-Chem is a leader in small molecule drug discovery services for pharmaceutical and biotechnology companies. As a pioneer in DNA-encoded chemical library (LED) technology, the company leverages its market-leading LED platform to uncover novel small molecule leads against challenging and high-value therapeutic targets. As experts in medicinal chemistry, X-Chem can take these leads and evolve them into clinical candidates with unparalleled speed. Throughout the process, X-Chem’s proprietary advanced artificial intelligence (AI) technology accelerates every step of the process. X-Chem also provides libraries, reagents and computational tools to enable LED operators to get the most out of their LED platform. X-Chem enables its partners to efficiently build drug pipelines from target to clinical candidate, enhanced with AI. For more information, please visit www.x-chemrx.com.